Cutera snags Vyaire Medical ’ s Mowry for CEO | Personnel Moves, July 9, 2019

Cutera (NSDQ:CUTR) said today that it snagged Vyaire Medical CEO David Mowry to be its new CEO, effective immediately. The aesthetic device maker in January fired president & CEO James Reinstein after the company missed expectations for its 2018 top line, naming COO Jason Richey as interim chief executive. Mowry led Tornier to a $3.3 billion merger with Wright Medical in October 2015. After leaving the COO role at Wright the next year, he was tapped to lead Vyaire Medical, a rollup of four respiratory businesses BD acquired in the March 2015 deal for CareFusion. Initially a joint venture partner in Vyaire with private equity shop Apax Partners, BD later dealt its 49.9% stake to Apax for $435 million. Mowry’s resume also includes a stint as president of Covidien’s neurovascular business, Brisbane, California-based Cutera said. “We are pleased to welcome David Mowry as Cutera’s CEO,” chairman Daniel Plants said in prepared remarks. “Dave is a highly regarded leader in the medical device industry, with a proven track record of building great businesses and creating shareholder value. We’re confident that Dave’s vision, operational discipline and commercial acumen make him the ideal leader for Cutera, and we’re excited to leverage his experience to help Cutera reach the next level. Cutera also said that its preliminary second-quarter numbers “exceeded consensus growth estimates and its own revenue forecast.” A...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Camstent Cerner Corp. Cutera Inc. Dentsply Sirona Inari Medical Medline Industries Inc. Neuronetics Ocular Therapeutix Personnel Moves Pfizer Pure Bioscience Source Type: news